David Bauer

David is a member of Davis Polk’s IP & Commercial Transactions practice. He advises clients on a wide range of IP and technology-related corporate and commercial transactions, including licensing and collaboration agreements, R&D agreements, supply and distribution agreements, and other strategic commercial and partnering agreements. He also advises on the IP and technology-related aspects of M&A transactions, joint ventures, financings, restructurings and capital markets offerings.

With a bioscience-related Ph.D., David has extensive experience and a particular focus advising clients in the pharmaceutical, biotechnology and medical device industries. His life sciences experience spans transactions across the world related to small molecule pharmaceuticals, biologics, cellular and gene therapies, diagnostics and medical devices. David also regularly advises clients in a variety of other industries, such as IT, media and financial services.